From: Results from early programmatic implementation of Xpert MTB/RIF testing in nine countries
Xpert site | Tests | MTB Positive | Rifampicin | Failed Tests | Type of failed test | MTB + w/o failed tests | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 |  | N | % | Sensitive | Indeterminate | Resistant | n | % | Error | Invalid | No result | |||||||
 |  |  |  | n | % | N | % | n | % |  |  | N | % | n | % | n | % |  |
Bangladesh | 1428 | 286 | 20.0% | 249 | 87.1% | 11 | 3.8% | 26 | 9.1% | 99 | 6.9% | 85 | 85.9% | 10 | 10.1% | 4 | 4.0% | 21.5% |
Cambodia | 3697 | 768 | 20.8% | 741 | 96.5% | 22 | 2.9% | 5 | 0.7% | 439 | 11.9% | 169 | 38.5% | 264 | 60.1% | 6 | 1.4% | 23.6% |
DR Congo | 6348 | 567 | 8.9% | 498 | 87.8% | 17 | 3.0% | 30 | 5.3% | 1032 | 16.3% | 868 | 84.1% | 107 | 10.4% | 57 | 5.5% | 10.7% |
Kenya | 2803 | 258 | 9.2% | 238 | 92.2% | 11 | 4.3% | 9 | 3.5% | 266 | 9.5% | 240 | 90.2% | 23 | 8.6% | 3 | 1.1% | 10.2% |
Malawi | 6258 | 632 | 10.1% | 602 | 93.5% | 9 | 1.4% | 21 | 3.3% | 853 | 13.6% | 546 | 64.0% | 265 | 31.1% | 42 | 4.9% | 11.7% |
Moldova | 11472 | 1965 | 17.1% | 1227 | 62.4% | 48 | 2.4% | 690 | 35.1% | 673 | 5.9% | 387 | 61.7% | 105 | 15.6% | 181 | 26.9% | 18.2% |
Mozambique | 6823 | 910 | 13.3% | 826 | 90.8% | 18 | 2.0% | 66 | 7.3% | 871 | 12.8% | 521 | 59.8% | 216 | 24.8% | 134 | 15.4% | 15.3% |
Nepal | 6943 | 1376 | 19.8% | 1257 | 91.4% | 14 | 1.0% | 105 | 7.6% | 744 | 10.7% | 409 | 55.0% | 148 | 19.9% | 187 | 25.1% | 22.2% |
Pakistan | 2201 | 433 | 19.7% | 390 | 90.1% | 13 | 3.0% | 30 | 6.9% | 130 | 5.9% | 77 | 59.2% | 37 | 28.5% | 16 | 12.3% | 20.9% |
All Countries | 47973 | 7195 | 15.0% | 6028 | 83.8% | 163 | 2.3% | 982 | 13.6% | 5107 | 10.6% | 3302 | 64.7% | 1175 | 23.0% | 630 | 12.3% | 16.8% |
South Africa a | 1180669 | 171792 | 14.6% | 155811 | 90.7% | 2443 | 1.4% | 12266 | 7.1% | 32561 | 2.8% | Â | Â | Â | Â | Â | Â | 15.0% |